Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function

Psychoneuroendocrinology

Volumn 37, Issue 7, 2012, Pages 1019-1028

  Pawluski, Jodi L ^a,b   Brain, Ursula M ^a   Underhill, Caroline M ^a   Hammond, Geoffrey L ^a   Oberlander, Tim F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antidepressants; Anxiety; Birth; Depression; Development; Motherhood; Pregnancy; Serotonin; Transcortin

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROCORTISONE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRANSCORTIN;

ADULT; ARTICLE; CHILD DEVELOPMENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; MALE; MATERNAL BEHAVIOR; MATERNAL TREATMENT; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERAL DEPRESSION; SALIVA LEVEL; VAGINAL DELIVERY;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SALIVA; SEROTONIN UPTAKE INHIBITORS; TRANSCORTIN;

EID: 84861193049     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.11.011     Document Type: Article

References (45)

1. Andrews M.H., Matthews S.G. Programming of the hypothalamo-pituitary-adrenal axis: serotonergic involvement. Stress 2004, 7:15-27.
2. Barden N., Reul J.M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?. Trends. Neurosci. 1995, 18:6-11.
3. Bremmer M.A., Deeg D.J., Beekman A.T., Penninx B.W., Lips P., Hoogendijk W.J. Major depression in late life is associated with both hypo- and hypercortisolemia. Biol. Psychiatry 2007, 62:479-486.
4. Brennan P.A., Pargas R., Walker E.F., Green P., Newport D.J., Stowe Z. Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J. Child. Psychol. Psychiatry 2008, 49:1099-1107.
5. Challis J.R., Berdusco E.T., Jeffray T.M., Yang K., Hammond G.L. Corticosteroid-binding globulin (CBG) in fetal development. J. Steroid Biochem. Mol. Biol. 1995, 53:523-527.
6. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. Am. J Obstet. Gynecol. 2007, 196. 544 e541-545.
7. Cox J.L., Holden J.M., Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 1987, 150:782-786.
8. Davidson S., Prokonov D., Taler M., Maayan R., Harell D., Gil-Ad I., Weizman A. Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr. Res. 2009, 65:236-241.
9. Davis E.P., Glynn L.M., Waffarn F., Sandman C.A. Prenatal maternal stress programs infant stress regulation. J. Child. Psychol. Psychiatry 2011, 52:119-129.
10. Deuschle M., Luppa P., Hamann B., Nonell A., Heuser I. Increased concentration of corticosteroid-binding globulin due to antidepressant treatment with amitritpyline, but not paroxetine. J. Psychiatr. Res. 2003, 37:85-87.
11. Erdeljan P., MacDonald J.F., Matthews S.G. Glucocorticoids and serotonin alter glucocorticoid receptor (GR) but not mineralocorticoid receptor (MR) mRNA levels in fetal mouse hippocampal neurons, in vitro. Brain. Res. 2001, 896:130-136.
12. Erdeljan P., Andrews M.H., MacDonald J.F., Matthews S.G. Glucocorticoids and serotonin alter glucocorticoid receptor mRNA levels in fetal guinea-pig hippocampal neurons, in vitro. Reprod. Fertil. Dev. 2005, 17:743-749.
13. Field T., Diego M., Hernandez-Reif M., Vera Y., Gil K., Schanberg S., Kuhn C., Gonzalez-Garcia A. Prenatal maternal biochemistry predicts neonatal biochemistry. Int. J. Neurosci. 2004, 114:933-945.
14. Field T., Diego M., Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant. Behav. Dev. 2006, 29:445-455.
15. Glover V., O'Connor T.G., O'Donnell K. Prenatal stress and the programming of the HPA axis. Neurosci. Biobehav. Rev. 2009, 35:17-22.
16. Goldkrand J.W., Schulte R.L., Messer R.H. Maternal and fetal plasma cortisol levels at parturition. Obstet. Gynecol. 1976, 47:41-45.
17. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
18. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
19. Hammond G.L., Lahteenmaki P.L. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin. Chim. Acta 1983, 132:101-110.
20. Isherwood D.M., Jenkins D.M., Perry L.A. Effects of delivery on fetal unbound cortisol concentration. Obstet. Gynecol. 1981, 57:215-219.
21. Kapoor A., Dunn E., Kostaki A., Andrews M.H., Matthews S.G. Fetal programming of hypothalamo-pituitary-adrenal function: prenatal stress and glucocorticoids. J. Physiol. 2006, 572:31-44.
22. King D.J. Plasma cortisol-binding capacity in mental illness. Psychol. Med. 1973, 3:53-65.
23. Ktiouet J., de Luca H.S., Zouaghi H., Toure-Saw H., Benkelfat C., Loo H. Decrease in transcortin binding activity in depression. Encephale 1984, 10:215-216.
24. Landgraf-Leurs M.M., Lange G., Leis D., Horn K., von Werder K., Muller O.A., Landgraf R. Hormonal profile and glucose tolerance in late pregnancy and postpartum. Horm. Metab. Res. 1983, 15:433-438.
25. Laplante P., Diorio J., Meaney M.J. Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain. Res. Dev. Brain. Res. 2002, 139:199-203.
26. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10:434-445.
27. McEwen B.S. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur. J. Pharmacol. 2008, 583:174-185.
28. Meaney M.J., Diorio J., Francis D., LaRocque S., O'Donnell D., Smythe J.W., Sharma S., Tannenbaum B. Environmental regulation of the development of glucocorticoid receptor systems in the rat forebrain. The role of serotonin. Ann. N. Y. Acad. Sci. 1994, 746:260-273. discussion 274, 289-293.
29. Oberlander T.F., Eckstein Grunau R., Fitzgerald C., Ellwood A.L., Misri S., Rurak D., Riggs K.W. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr. Res. 2002, 51:443-453.
30. Oberlander T.F., Grunau R.E., Fitzgerald C., Papsdorf M., Rurak D., Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005, 115:411-425.
31. Oberlander T.F., Warburton W., Misri S., Aghajanian J., Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch. Gen. Psychiatry 2006, 63:898-906.
32. Oberlander T.F., Grunau R., Mayes L., Riggs W., Rurak D., Papsdorf M., Misri S., Weinberg J. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early. Hum. Dev. 2008, 84:689-697.
33. Oberlander T.F., Weinberg J., Papsdorf M., Grunau R., Misri S., Devlin A.M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008, 3:97-106.
34. Oberlander T.F., Papsdorf M., Brain U.M., Misri S., Ross C., Grunau R.E. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch. Pediatr. Adolesc. Med. 2010, 164:444-451.
35. Perogamvros I., Aarons L., Miller A.G., Trainer P.J., Ray D.W. Corticosteroid-binding globulin regulates cortisol pharmacokinetics. Clin. Endocrinol. (Oxf.) 2011, 74:30-36.
36. Richard E.M., Helbling J.C., Tridon C., Desmedt A., Minni A.M., Cador M., Pourtau L., Konsman J.P., Mormede P., Moisan M.P. Plasma transcortin influences endocrine and behavioral stress responses in mice. Endocrinology 2010, 151:649-659.
37. Scrocchi L.A., Orava M., Smith C.L., Han V.K., Hammond G.L. Spatial and temporal distribution of corticosteroid-binding globulin and its messenger ribonucleic acid in embryonic and fetal mice. Endocrinology 1993, 132:903-909.
38. Seralini G.E., Underhill C.M., Smith C.L., Nguyen V.T., Hammond G.L. Biological half-life and transfer of maternal corticosteroid-binding globulin to amniotic fluid in the rabbit. Endocrinology 1989, 125:1321-1325.
39. Siiteri P.K., Murai J.T., Hammond G.L., Nisker J.A., Raymoure W.J., Kuhn R.W. The serum transport of steroid hormones. Recent Prog. Horm. Res. 1982, 38:457-510.
40. Smith C.L., Hammond G.L. Ontogeny of corticosteroid-binding globulin biosynthesis in the rat. Endocrinology 1991, 128:983-988.
41. Talbert L.M., Pearlman W.H., Potter H.D. Maternal and fetal serum levels of total cortisol and cortisone, unbound cortisol, and corticosteroid-binding globulin in vaginal delivery and cesarean section. Am. J. Obstet. Gynecol. 1977, 129:781-787.
42. Tamashiro K.L., Moran T.H. Perinatal environment and its influences on metabolic programming of offspring. Physiol. Behav. 2010, 100:560-566.
43. Van den Bergh B.R., Van Calster B., Smits T., Van Huffel S., Lagae L. Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008, 33:536-545.
44. Ververs T., Kaasenbrood H., Visser G., Schobben F., de Jong-van den Berg L., Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur. J. Clin. Pharmacol. 2006, 62:863-870.
45. Vieta E., Gasto C., Osaba M.M., Otero A., Nieto E., Pintor L., Blanch J., Vallejo J. Cortisol-binding globulin levels in bipolar disorder. Eur. Psychiatry 1997, 12:11-15.